HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Sept. 22, 2022 (HealthDay News) -- Neuropsychiatric presentations, including seizure, confusion, and encephalitis, have been reported among patients with monkeypox infection, according to a review published online Sept. 8 in eClinicalMedicine.
James B. Badenoch, M.B.Ch.B., from Barts Health NHS Trust in London, and colleagues conducted a systematic review and meta-analysis to examine neuropsychiatric presentations of monkeypox infection. Data were reviewed from 19 eligible studies with 1,512 participants (1,031 with confirmed infection using criteria from the U.S. Centers for Disease Control and Prevention or polymerase chain reaction testing).
The researchers found that the quality of studies was generally moderate. Three clinical features were eligible for meta-analysis: seizure, confusion, and encephalitis, which had pooled prevalence rates of 2.7, 2.4, and 2.0 percent, respectively. Myalgia, headache, and fatigue were also frequently reported symptoms, although pooled prevalence could not be estimated due to heterogeneity being too high, possibly as a result of differences in viral clades and study methodology.
"We found that severe neurological complications such as encephalitis and seizures, while rare, have been seen in enough monkeypox cases to warrant concern, so our study highlights a need for further investigation," a coauthor said in a statement. "There is also evidence that mood disorders such as depression and anxiety are relatively common for people with monkeypox."
One author disclosed financial ties to the pharmaceutical industry.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Published on September 22, 2022